Migraine prophylaxis with botulinum toxin A is associated with perception of headache.

Burstein R, Dodick D, Silberstein S. Migraine prophylaxis with botulinum toxin A is associated with perception of headache. Toxicon. 2009 Oct; 54(5):624-7.

View in: PubMed

subject areas

Adult
Aged
Botulinum Toxins, Type A
Female
Humans
Male
Middle Aged
Migraine Disorders
Neuromuscular Agents
Pain
Pain Measurement
Retrospective Studies
Statistics, Nonparametric
Treatment Outcome
Young Adult

authors with profiles

Stephen Silberstein
David Dodick

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement